Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

The hydrogels improve wound healing and tissue regeneration better than traditional treatments.

Pregnant women with rheumatic diseases often have poor nutrition, needing more folic acid, calcium, and iron, while consuming too much selenium.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

Spironolactone and metformin work similarly for PCOS symptoms, but more research is needed.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Evidence-based medicine needs improvement to better tailor treatments to individual patients.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Dermatologists are crucial in providing personalized care for patients with sex development differences.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.